ARCHIVES

ASCO, AACR Call NCI Bypass Budget A Key Advocacy Tool, Seek Larger Role In Writing It.

This article is from The Cancer Letter archive.

Vol. 26 No. 28 | July 14, 2000

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page Issue: Safety Warnings Are Added to Labels for Epo and Avastin.

January 21, 2005

Other DCT Concepts Approved By BSC

June 6, 1986

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

March 28, 2008

Major Changes Being Considered By NCI For FCRA

April 14, 1978

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

November 23, 1979

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012